We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$712B
AUM Growth
+$77.7B
Cap. Flow
+$6.45B
Cap. Flow %
0.91%
Top 10 Hldgs %
29.74%
Holding
13,792
New
1,607
Increased
5,174
Reduced
5,388
Closed
1,330

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.51B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.53B
3
AMZN icon
Amazon
AMZN
+$1.11B
4
ABNB icon
Airbnb
ABNB
+$574M
5
NVDA icon
NVIDIA
NVDA
+$519M

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.77%
2 Consumer Discretionary 1.94%
3 Technology 1.9%
4 Communication Services 1.42%
5 Financials 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TALK
11376
PUT
DELISTED
Talkspace
TALK
$214K ﹤0.01%
+25,800
New +$251K
WSR
11377
CALL
DELISTED
Whitestone REIT
WSR
$214K ﹤0.01%
+25,900
New +$233K
CCV
11378
PUT
DELISTED
Churchill Capital Corp V
CCV
$214K ﹤0.01%
+21,300
New +$213K
AORT icon
11379
CALL
Artivion
AORT
$1.31B
$213K ﹤0.01%
7,500
-26,600
-78% -$725K
EIDO icon
11380
PUT
iShares MSCI Indonesia ETF
EIDO
$492M
$213K ﹤0.01%
10,500
-17,500
-63% -$377K
IAT icon
11381
PUT
iShares US Regional Banks ETF
IAT
$663M
$213K ﹤0.01%
+3,700
New +$219K
IXUS icon
11382
CALL
iShares Core MSCI Total International Stock ETF
IXUS
$61B
$213K ﹤0.01%
+2,900
New +$212K
MLPA icon
11383
Global X MLP ETF
MLPA
$2.36B
$213K ﹤0.01%
+5,522
New +$203K
STIM icon
11384
Neuronetics
STIM
$226M
$213K ﹤0.01%
13,317
-104,570
-89% -$1.44M
TVTX icon
11385
PUT
Travere Therapeutics
TVTX
$6.3B
$213K ﹤0.01%
14,600
-6,200
-30% -$122K
WHG icon
11386
Westwood Holdings Group
WHG
$193M
$213K ﹤0.01%
+9,779
New +$186K
GRTS
11387
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$213K ﹤0.01%
+23,379
New +$216K
CAMP
11388
DELISTED
CalAmp Corp.
CAMP
$213K ﹤0.01%
728
+12
+2% +$3.58K
ARRWU
11389
DELISTED
Arrowroot Acquisition Corp. Unit
ARRWU
$213K ﹤0.01%
21,268
NXGN
11390
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$213K ﹤0.01%
12,853
-4,175
-25% -$74.8K
PHAS
11391
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$213K ﹤0.01%
57,284
+499
+0.9% +$1.66K
ATAQ.U
11392
DELISTED
Altimar Acquisition Corp III Units
ATAQ.U
$213K ﹤0.01%
21,124
MTL
11393
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$213K ﹤0.01%
+104,971
New +$215K
ITM icon
11394
PUT
VanEck Intermediate Muni ETF
ITM
$2.12B
$212K ﹤0.01%
4,100
+200
+5% +$10.3K
JAGX icon
11395
PUT
Jaguar Health
JAGX
$4.95M
0
MSEX icon
11396
CALL
Middlesex Water
MSEX
$1.09B
$212K ﹤0.01%
+2,600
New +$215K
PNFP icon
11397
PUT
Pinnacle Financial Partners Inc
PNFP
$15.2B
$212K ﹤0.01%
+2,400
New +$215K
RGLS
11398
PUT
DELISTED
Regulus Therapeutics
RGLS
$212K ﹤0.01%
26,120
+19,590
+300% +$219K
STRO icon
11399
PUT
Sutro Biopharma
STRO
$359M
$212K ﹤0.01%
1,140
-400
-26% -$78.3K
XPP icon
11400
PUT
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$8.61M
$212K ﹤0.01%
3,000
-400
-12% -$28.1K

Similar funds

Jeff Yass's Q2 2021 Portfolio in Review

As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
  • Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
  • Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
  • Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
  • Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
  • Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
  • Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.